How many insider trades does FilingIQ track for DMRA?

FilingIQ tracks 4 Form 4 insider transactions for DMRA (Galecto, Inc.), covering filings from Apr 1, 2026 onwards. 1 of those are dated within the last 90 days.

Are DMRA insiders net buyers or net sellers?

Across the full Form 4 history for DMRA, 1 transactions (25%) were open-market purchases and 1 (25%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does DMRA insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.

What sector is DMRA in?

Galecto, Inc. (DMRA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.86B.

DMRA insider trading

Healthcare

Galecto, Inc.: insider trade history from SEC Form 4 filings.

Total Form 4 trades

Last 90 days

Buys / sells

25% / 25%

Market cap

$1.86B

About Galecto, Inc.

Galecto, Inc., a clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company develops GB3226, a preclinical small molecule dual inhibitor of ENL-YEATS and FLT3 and GB1211, an oral small molecule inhibitor of galectin-3 to treat multiple types of oncology and liver disease indications. Galecto, Inc. was founded in 2011 and is headquartered in Copenhagen, Denmark.

Company website: galecto.com

DMRA insider activity at a glance

FilingIQ tracks 4 insider transactions for DMRA in filings since Apr 1, 2026. The most recent transaction is dated Sep 25, 2026.

Across the full history, 1 open-market purchases and 1 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on DMRA insider trades is 68.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live DMRA trades on FilingIQ Raw filings on SEC EDGAR

Latest DMRA Form 4 filings

Jarrett Jennifer Director, President and CEO

P Sep 28, 2026

Cheng Andrew

A Aug 13, 2026

Winslow Garrett General Counsel

SM Jul 7, 2026

Jarrett Jennifer See Remarks

A Apr 1, 2026

Winslow Garrett General Counsel

Fairmount Funds Management LLC

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 820

UNITED THERAPEUTICS Corp

THERMO FISHER SCIENTIFIC INC.

NTRA 129

Natera, Inc.

ATTO 123

Attovia Therapeutics, Inc.

CORT 110

CORCEPT THERAPEUTICS INC

TEM 104

Tempus AI, Inc.

13F funds holding DMRA

a16z Capital Management, L.L.C.

$32.15M · 0.2% of AUM

Frequently asked

How many insider trades does FilingIQ track for DMRA?: FilingIQ tracks 4 Form 4 insider transactions for DMRA (Galecto, Inc.), covering filings from Apr 1, 2026 onwards. 1 of those are dated within the last 90 days.
Are DMRA insiders net buyers or net sellers?: Across the full Form 4 history for DMRA, 1 transactions (25%) were open-market purchases and 1 (25%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does DMRA insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
What sector is DMRA in?: Galecto, Inc. (DMRA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.86B.

Methodology & sources

Every DMRA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.